WilliamEdwardBurakJr.MDFACS

PubMed

• Preoperative Predictive Factors of Positive Margin Status After Breast Conserving Therapy (BCT) with Intraoperative Radiation Therapy (IORT): A Retrospective Study of ...
  Christina Munford, Eric Clayton, Dabin Ji, Joshua R. Eskew, William E. Burak> ;Clinical Breast Cancer. 2020 Apr 7
• Adherence to the National Quality Forum (NQF) breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010.
  Wilke LG Ballman KV McCall LM Giuliano AE Whitworth PW Blumencranz PW Reintgen DS Burak WE Leitch AM Hunt KK> ;Ann Surg Oncol. 2010 Aug
• Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast can...
  Povoski SP Olsen JO Young DC Clarke J Burak WE Walker MJ Carson WE Yee LD Agnese DM Pozderac RV Hall NC Farrar WB> ;Ann Surg Oncol. 2006 Nov
• Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer.
  Posther KE McCall LM Blumencranz PW Burak WE Jr Beitsch PD Hansen NM Morrow M Wilke LG Herndon JE 2nd Hunt KK Giuliano AE> ;Ann Surg. 2005 Oct
• 7 citations
  Phase II trial of neoadjuvant chemotherapy with docetaxel followed by epirubicin in stage II/III breast cancer.
  Bhuvaneswari Ramaswamy, Steven P. Povoski, Chris A. Rhoades, Joan Allen, Marsha Hauger, Donn C. Young, William E. Burak, William B. Farrar, Lisa D. Yee, Kari Kendra, S...> ;Breast Cancer Research and Treatment. 2005 Sep 1
• Ablative approaches to the minimally invasive treatment of breast cancer.
  Agnese DM Burak WE Jr> ;Cancer J. 2005 Jan-Feb
• 16 citations
  Advances in the surgical management of early stage invasive breast cancer
  William E. Burak, Doreen M. Agnese, Stephen P. Povoski> ;Current Problems in Surgery. 2004 Nov 1
• Trends in breast cancer presentation and care according to age in a single institution.
  Agnese DM Yusuf F Wilson JL Shapiro CL Lehman A Burak WE Jr> ;Am J Surg. 2004 Oct
• Breast cancer chemoprevention phase I evaluation of biomarker modulation by arzoxifene, a third generation selective estrogen receptor modulator.
  Fabian CJ Kimler BF Anderson J Tawfik OW Mayo MS Burak WE Jr O'Shaughnessy JA Albain KS Hyams DM Budd GT Ganz PA Sauter ER Beenken SW Grizzle WE Fruehauf...> ;Clin Cancer Res. 2004 Aug 15
• Pilot study using a humanized CC49 monoclonal antibody (HuCC49DeltaCH2) to localize recurrent colorectal carcinoma.
  Agnese DM Abdessalam SF Burak WE Jr Arnold MW Soble D Hinkle GH Young D Khazaeli MB Martin EW Jr> ;Ann Surg Oncol. 2004 Feb
• Isolated supraclavicular lymph node recurrence after breast-conserving surgery and negative axillary sentinel node biopsy.
  Agnese DM Williams J Burak WE Jr> ;Breast J. 2003 Nov-Dec
• Cost-effectiveness of sentinel lymph node biopsy in thin melanomas.
  Agnese DM Abdessalam SF Burak WE Jr Magro CM Pozderac RV Walker MJ> ;Surgery. 2003 Oct
• Low-risk palpable breast masses removed using a vacuum-assisted hand-held device.
  Fine RE Whitworth PW Kim JA Harness JK Boyd BA Burak WE Jr> ;Am J Surg. 2003 Oct
• Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision.
  Burak WE Jr Agnese DM Povoski SP Yanssens TL Bloom KJ Wakely PE Spigos DG> ;Cancer. 2003 Oct 1
• Older women with breast carcinoma are less likely to receive adjuvant chemotherapy: evidence of possible age bias?
  Woodard S Nadella PC Kotur L Wilson J Burak WE Shapiro CL> ;Cancer. 2003 Sep 15
• Is neoadjuvant therapy the answer to adenocarcinoma of the esophagus?
  Burak WE Jr> ;Am J Surg. 2003 Sep
• Positron emission tomography affects surgical management in recurrent colorectal cancer patients.
  Desai DC Zervos EE Arnold MW Burak WE Jr Mantil J Martin EW Jr> ;Ann Surg Oncol. 2003 Jan-Feb
• 48 citations
  Patterns of recurrence after sentinel lymph node biopsy for breast cancer.
  Brian D. Badgwell, Stephen P. Povoski, Shahab F. Abdessalam, Donn C. Young, William B. Farrar, Michael Walker, Lisa D. Yee, Emmanuel E. Zervos, William E. Carson, Will...> ;Annals of Surgical Oncology. 2003 May 1
• 76 citations
  Percutaneous removal of benign breast masses using a vacuum-assisted hand-held device with ultrasound guidance
  Richard E. Fine, Beth A Boyd, Pat Whitworth, Julian A Kim, Jay K Harness, William E. Burak> ;American Journal of Surgery. 2002 Oct 1
• Lymphatic mapping in solid neoplasms: state of the art.
  Zervos EE Burak WE Jr> ;Cancer Control. 2002 May-Jun
• Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer.
  Burak WE Hollenbeck ST Zervos EE Hock KL Kemp LC Young DC> ;Am J Surg. 2002 Jan
• Importance of quality breast imaging in symptomatic women.
  Burak WE Jr Lerner AG> ;Radiology. 2002 Mar
• 33 citations
  Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and n...
  Emmanuel E. Zervos, Brian D. Badgwell, William E. Burak, Mark Arnold, Edward W. Martin> ;Surgery. 2001 Oct 1
• 129 citations
  Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer
  Shahab F. Abdessalam, Emmanuel E. Zervos, Manju L. Prasad, William B. Farrar, Lisa D. Yee, Michael Walker, William B Carson, William E. Burak> ;American Journal of Surgery. 2001 Oct 1
• 24 citations
  Selective analysis of the sentinel node in breast cancer
  Emmanuel E. Zervos, Brian D. Badgwell, Shahab F. Abdessalam, William B. Farrar, Michael J. Walker, Lisa D. Yee, William E. Burak> ;American Journal of Surgery. 2001 Oct 1
• Join now to see all

Journal Articles

• Surgical Cost Analysis of the Reduction in Mastectomy Rate Seen with Implementation of an Intraoperative Radiation Program  
  Christina Munford, Elena T Rehl, William E Burak, Journal of The American College of Surgeons